BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25108493)

  • 21. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic value of SYNTAX score for outcomes and revascularization strategy choice in ST-segment elevation myocardial infarction patients with multivessel coronary artery disease].
    Tarasov RS; Ganiukov VI; Shilov AA; Barbarash OL; Barbarash LS
    Ter Arkh; 2012; 84(9):17-21. PubMed ID: 23091848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revascularization options: coronary artery bypass surgery and percutaneous coronary intervention.
    Kappetein AP; van Mieghem NM; Head SJ
    Cardiol Clin; 2014 Aug; 32(3):457-61. PubMed ID: 25091970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
    Kim MC; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Cho SY; Rha SW; Bae JH; Cho JG; Park SJ;
    Int J Cardiol; 2011 Dec; 153(2):148-53. PubMed ID: 20843572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements.
    Généreux P; Palmerini T; Caixeta A; Cristea E; Mehran R; Sanchez R; Lazar D; Jankovic I; Corral MD; Dressler O; Fahy MP; Parise H; Lansky AJ; Stone GW
    Circ Cardiovasc Interv; 2011 Dec; 4(6):553-61. PubMed ID: 22028472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
    Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions.
    Capodanno D; Tamburino C
    Am Heart J; 2011 Mar; 161(3):462-70. PubMed ID: 21392599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widening clinical applications of the SYNTAX Score.
    Farooq V; Head SJ; Kappetein AP; Serruys PW
    Heart; 2014 Feb; 100(4):276-87. PubMed ID: 23878176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial.
    Palmerini T; Caixeta A; Genereux P; Cristea E; Lansky A; Mehran R; Dangas G; Lazar D; Sanchez R; Fahy M; Xu K; Stone GW
    Am Heart J; 2012 Mar; 163(3):383-91, 391.e1-5. PubMed ID: 22424008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery Trial and Registry.
    Parasca CA; Head SJ; Mohr FW; Mack MJ; Morice MC; Holmes DR; Feldman TE; Colombo A; Dawkins KD; Serruys PW; Kappetein AP;
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):597-606.e2. PubMed ID: 26055439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
    Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.
    Elbarasi E; Goodman SG; Yan RT; Welsh RC; Kornder J; Wong GC; Déry JP; Anderson F; Gore JM; Fox KA; Yan AT; ;
    Am Heart J; 2010 Jan; 159(1):40-6. PubMed ID: 20102865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?
    Ferguson TB; Chen C; Babb JD; Efird JT; Daggubati R; Cahill JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):824-835.e1. PubMed ID: 23915918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of syntax score: from core lab to real world.
    Tanboga IH; Ekinci M; Isik T; Kurt M; Kaya A; Sevimli S
    J Interv Cardiol; 2011 Aug; 24(4):302-6. PubMed ID: 21722184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
    Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).
    Caixeta A; Généreux P; Palmerini T; Lansky AJ; Mehran R; Dangas GD; Xu K; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):203-10. PubMed ID: 24176063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
    Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
    Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
    Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Torracca L; van Es GA; Leadley K; Dawkins KD; Mohr F
    Circulation; 2010 Jun; 121(24):2645-53. PubMed ID: 20530001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.